Effect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative Course and the Immune Response in Patients Undergoing Surgery for Colon Cancer -

Effect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative Course and the Immune Response in Patients Undergoing Surgery for Colon Cancer - the PILDI Study is a phase 2, randomised interventional study registered as NCT06923787 by Institute of Oncology Ljubljana, with a registry enrolment figure of 100 participants, started 2026-02-03 and due to reach its primary completion in 2027-07-01. Interventions recorded: Lidocaine; Placebo. Conditions listed: Colon Cancer. Primary outcome: Difference in opioid use in 24 hours after surgery between arms. Colorectal eligibility wording from the registry: "* colon cancer of any stage of the disease for which elective laparoscopic colon resection and colonic anastomosis will be performed,". Sites: Slovenia. No results are recorded here; the registry entry is the source.